Press conference with Minister Butler, Canberra – 16 November 2026

Read the transcript of Minister Butler's press conference on NHMRC advice on puberty suppressants, bulk billing, National Disability Insurance Scheme, Wegovy, Helen Haines, Support at Home packages, MYEFO, and electorate office.

The Hon Mark Butler MP
Minister for Health and Ageing
Minister for Disability and the National Disability Insurance Scheme

Media event date:
Date published:
Media type:
Transcript
Audience:
General public

MARK BUTLER, MINISTER FOR HEALTH AND AGEING, MINISTER FOR DISABILITY AND THE NDIS: Afternoon, everyone. Earlier today, the National Health and Medical Research Council published its advice on the use of puberty suppressants in the treatment and care of children and adolescents with gender dysphoria. These replace guidelines that were first published in 2018. Those guidelines were not endorsed by the National Health and Medical Research Council. This is an area that I described earlier last year as complex and evolving, especially given that it relates to minors, and minors who are often quite vulnerable. The Cass Review of practices in this area in the United Kingdom that was delivered in 2024 led to a heightened debate and public commentary around this area. And so early last year, early in 2025, I asked the National Health and Medical Research Council to review all available evidence and to develop new national guidelines for the care of trans and gender diverse children and adolescents.

The National Health and Medical Research Council has a history stretching back decades in the development of clinical guidelines. It is without a doubt the preeminent authority in Australia for health and medical research, and it has a statutory role set out in Commonwealth legislation to develop clinical guidelines for application through the Australian healthcare system. I also asked that they publish early advice on the use of puberty suppressants, often described as puberty blockers, in the treatment and care of those young Australians, and that advice has been published today. The advice will be open for public comment until 18 January, and the remainder of the clinical guidelines beyond the use of puberty suppressants will be developed over the course of the coming period leading probably into 2028. That particularly will cover things like the provision of psychosocial support to children and adolescents, and also the use and the prescribing of hormone treatments.

This is, I think it’s fair to say, an area of clinical practice that attracts a lot of public commentary and public debate. And that is understandable, given we’re talking about children and adolescents, particularly children and adolescents who are often quite vulnerable. Not all of that public commentary and debate is always constructive, and frankly sometimes it runs the risk of being quite damaging, particularly damaging to the mental health of those young Australians and their families. We’re talking about a relatively small group of young people, but it is a growing group. Advice and research indicates that a larger number today of adolescent Australians identify as trans or gender diverse than was the case even as recently as the last decade. These young Australians are also vastly overrepresented in mental health and suicide prevention statistics, reflecting still very high levels of stigma and discrimination generally around these issues in the population, and obviously, the fact that these Australians are going through a very significant period of their development being childhood and adolescence.

For all of those reasons, I thought and I think generally people involved in this debate agree, it was especially important to give those young Australians, their families and the broader community, frankly, the greatest possible confidence that clinicians treating and caring for these young Australians have access to and are using the best possible clinical guidelines when they’re caring and supporting young people with gender incongruence, or particularly gender dysphoria.

Now, the National Health and Medical Research Council advice that was published a little while ago today suggests that puberty blockers, or puberty suppressants, can be used in certain circumstances, and subject to a range of conditions. Those conditions include, obviously, a process of shared decision making and consent by the young people, by clinicians, and importantly by parents. It also involves the need for a comprehensive health assessment to be undertaken of the young person that involves multidisciplinary input. And importantly as well, if these medicines are prescribed, very regular monitoring of the health of the young patient.

Now, these services historically have been pretty much exclusively delivered in state or territory government-run paediatric gender clinics. And these services have for many years involved multidisciplinary teams of clinicians who in turn are employed by state governments. The NHMRC in its advice points to a series of data from a number of those services, including the big services in Melbourne, for example, suggesting the prescription of puberty blockers to maybe several dozen young people over the course of several years. It also suggests that prescription of puberty blockers and hormones, for that matter, usually involve extensive periods of support that the clinic or the service has provided to young people, in the Melbourne case, which is the largest gender clinic in Australia, on average for 530 days before any prescription of medicine is undertaken. Now, state governments obviously have the responsibility to ensure the highest quality, best possible care and support to all of their patients, including these young Australians. And I’m very confident that those state governments running these services will consider this advice very closely and make sure that their services are aligning with it.

Now, there is no hard evidence of any private prescribing of puberty suppressants to young Australians in Australia, although I know there has been some reportage of this maybe starting to happen particularly since a change of practice in Queensland. That is an important contrast with the United Kingdom, where a lot of the more recent debate has started. My former colleague, Health Minister Wes Streeting, made a statement to the UK Parliament in late 2024, where he pointed to pretty questionable private prescribing practices in that country which often involved simply the completion of an online questionnaire and a single Zoom call with a prescribing practitioner who was sometimes not even in the UK. And as a result of the evidence of those practices in the UK, the UK health secretary Wes Streeting then imposed a ban on the prescription of these medicines by private prescribers.

Now, as I said, there's no hard evidence of that practice here in Australia, but I will be asking my department to monitor this area closely to determine whether or not there is any expansion of this practice beyond the traditional state-run paediatric gender services. And were there to emerge evidence of the sort of private practices we saw in the UK, and we are seeing some of these practices in other adult prescribing areas, then we would look at making sure that we could take action to ensure the quality of care and treatment to those young Australians through private providers, as we expect there will be through state and territory-run gender services.

Sorry, there was a little bit in that. This is an important piece of advice from our preeminent health and medical research body. I'm now happy to take questions. Yes?

JOURNALIST: Minister, should the Queensland and Northern Territory governments abandon their bans on puberty blockers, given this advice? And will the federal government fund hormone suppressant Triptorelin under the PBS for gender affirming care?

BUTLER: To your second question first, the prescription of puberty blockers or puberty suppressants right around the world, as far as I know, is undertaken on an off-label basis. And what that means essentially is it's not reimbursed through arrangements like the Pharmaceutical Benefits Scheme because there have not been the sort of clinical trials and the evidence that is usually important to justify a reimbursement decision through the PBS. And you see that through Europe and the UK and other jurisdictions as well, so we don't propose to make any change to that. This would continue as an off-label prescribing practice.

To your first question around Queensland and the Northern Territory, as I said, services traditionally are run by state governments through clinicians employed by state governments. It's a matter for the state governments to determine the way in which those services operate. I know traditionally, state governments of both political persuasions have always paid high regard to the advice of the National Health and Medical Research Council, it's been there for decades. It's provided this clinical advice for many decades as well. Its reputation is unimpeachable. But ultimately, these are decisions for state and territory governments.

JOURNALIST: Do you expect, though, those two states and territories will follow this advice?

BUTLER: I can't look into their mind. I'm sure they'll consider it closely. The Queensland government undertook a particular review of their services as well, it didn't have the status, or the scope, or purpose of the NHMRC work that has been delivered on an interim basis, if you like, or early basis for puberty suppressants, and is ongoing for other aspects of this area of care. But ultimately, the Queensland Government will have to make its own decisions.

JOURNALIST: The jurisdictions that are providing this care already. With the new, are you expecting the new guidelines they're followed, that would reduce the amount of children that are on puberty blockers, or remain the same?

BUTLER: The advice that I've received from clinicians who don't practice in this area but that are active in youth mental health, Professor Anne Hickey has been quite public about this, indicate that the model of care applied in most state and territories, I think all state and territories, reflects the sort of model that you now see in the UK clinical trial, the pathways clinical trial. It's much more multidisciplinary and involves significant monitoring of the patient. And probably reflects the sort of conditions that I talked about have been incorporated into the NHMRC advice.

JOURNALIST: Minister, I was looking at the bulk billing data that you put out earlier today, and I know we've asked you about this before. I think your national average is up around 76 or 80 or thereabouts. In the ACT, it's in the 50s, 20 points behind everybody else. I know that you, can you explain to me why you think that's happening? And can you tell us again what you're trying to do about it? Because I know you tried to create market forces. And finally, what is your message to GPs in the ACT?

BUTLER: There is absolutely no justification for Canberra patients being charged gap fees that are way out of whack with the sorts of fees that are paid in a big city like Sydney. And yet we see that continue to be the case in spite of significant investment through the Commonwealth Government in bulk billing support for GPs. It is a cultural market issue. There is no significant rationale. There is no serious rationale for Canberra patients having to pay a higher gap fee than a patient in Sydney where operating a business is more expensive than operating one here in Canberra. I make the same argument about Newcastle, which is really probably the other outlier in terms of bulk billing here.

We're not willing to stand by and see groups in the Australian community, whether they're in Canberra or Newcastle or elsewhere, not get the benefit of the significant investment in bulk billing services that we've made over the last few years. And that is why we're intervening in the market in Canberra to shake it up a bit, to put in place -

JOURNALIST: But it’s not working, is it?

BUTLER: It's not working so far. These are still very new practices, We're doing it in Newcastle as well, really, as we speak. And if we need to do more, we're going to do more. We're not going to sit by and simply let a big group of Australians not get the benefit of bulk billing support that other Australians enjoy.

JOURNALIST: Are Canberra doctors just greedy?
 
BUTLER: There are cultural factors operating in some markets where particular groups of doctors feel they can continue to charge gap fees that you don't see in other very significant, often quite expensive, markets in the country. Mark.

JOURNALIST: Minister, have you considered banning non-citizens from the NDIS? And what impact would that have on the scheme and those people?

BUTLER: I've seen reports of a Liberal Party policy to exclude permanent residents from the NDIS. This is a big change to the eligibility rules that the former coalition government put in place in the first place when the NDIS was being set up. And permanent residents remember, these are people who we expect to stay in Australia forever and are on a pathway to citizenship, they just have to serve some years as PRs or permanent residents before they do that, have always been able to access basic social support systems, particularly in healthcare and disabilities. To chuck them off the scheme would be a very significant thing to do.

The first thing I'll say about this is you cannot come to Australia as a migrant with a significant disability or health care condition. There are quite clear, long-standing thresholds in terms of your future health care costs that would bar you from being able to come to Australia as a permanent resident, they've long been in place. There are not many people coming to Australia to become permanent residents and then going on to the NDIS.

I question their shoddy numbers. They appear to have applied a simple 10 per cent of the population being permanent residents being 10 per cent of the NDIS costs, completely ignoring the fact that you cannot come to this country as an immigrant with a significant disability or healthcare condition. I also raise the question. If you do come here as a permanent resident and you've set up your life here, you're on a pathway to citizenship, your children are in school, you're in a job, we've told you as a government that you can stay here for the rest of your life, and you do suffer a catastrophic injury that enrols you into the NDIS, what does the coalition government say your future looks like? Are you just simply thrown onto the street?

I think there are a lot of answers for the coalition to give to us here. Firstly, show us the numbers, demonstrate that those savings are actually there. And then explain to the Australian community what the future holds for people who are part of our community, a significant part of our community, if they become catastrophically injured.

JOURNALIST: The council's interim advice appears to be contradictory to the CASS Review. How is the guidance acceptable in light of this?

BUTLER: Let me say first of all, to your final word, I think I have the utmost respect for the National Health and Medical Research Council. And I think the role that it has long played in this country, at arm's length from the government of the day and the political process, to provide the highest quality clinical advice to health practitioners and the community more generally, should always be respected.

And that's why I ask them to try and review the evidence, to review the evidence, and issue some pre-eminent guidelines to guide this contested, evolving area that's the subject of so much public commentary and involves some of our most vulnerable members of the community. I'm not going to question the advice or make some sort of qualitative judgement about the advice of our most eminent clinicians that have been doing this.

In terms of the difference to the CASS Review. Again, I think this has been the subject of quite a deal of public commentary. I think if you look at what led to the CASS Review, the practice that was in question in the UK. It’s quite different, first of all, to the model of care that has traditionally been applied here in Australia. And secondly, to the conditions that are quite clearly enunciated in the NHMRC advice. If you look at the pathway clinical trial that the UK has put in place, that essentially involves young people being enrolled and being able to be prescribed puberty suppressants, the design of that clinical trial quite closely reflects the conditions that the NHMRC has set out in its advice today.

JOURNALIST: PBAC had a recent meeting, and part of that was to consider Wegovy going onto the Pharmaceutical Benefits Scheme to treat obesity. Do you have an indication of when a decision might be made on that, or when you would like to see that process finalised?

BUTLER: I haven't got advice about that. I think it was matter of public record that there was another meeting, I think this month in November, the PBAC to see if they could reach a reimbursement decision acceptable to the sponsor. I haven't got advice about the outcome of that meeting yet.

JOURNALIST: On Queensland and the Northern Territory, they do not heed the advice on puberty blockers. Is that something that you would urge them to reconsider? Could the federal government step in?

BUTLER: The federal government can't step in. These are state-run services, as state hospitals are state-run services. Ultimately, the Queensland government is accountable to the Queensland people for the way in which they run all of their hospital services. I am very confident that every state government, no matter their political persuasion, will consider the advice of our preeminent authority very closely. Whether that leads to a change in policy by either the Queensland or NT Government is really a matter for them. You haven’t had a go.

JOURNALIST: Sorry. You said in the case of it was a couple of dozen over a few years. Was that just in Melbourne or across the country?

BUTLER: Yeah. If you look at the advice, the largest gender clinic in Australia is the Melbourne Gender Clinic or Paediatric Gender Clinic. And from memory, over a period of eight years, this is set out in the NHMRC advice, but over a period of eight years, there were 64 young people prescribed puberty suppressants over those eight years at the biggest clinic. The number, from recollection, was a little higher in the Perth clinic that was also canvassed in the NHMRC report. Larger numbers of young people, generally in their later teens, were prescribed hormones, and that will be the subject of further advice from the NHMRC. Yes?

JOURNALIST: Minister, the Commonwealth Ombudsman released a scathing review into the Integrated Assessment Tool and how it works in the aged care Support at Home packages. It's something that you've staunchly defended as providing fair outcomes, except the Ombudsman says exactly the opposite of that. What's the government's response to that, and why wait for an independent review from the government if the ombudsman has already told you what to do and what to change?

BUTLER: A number of the recommendations from the ombudsman were already being actioned by the government at the time that the ombudsman report was delivered. Obviously, the most important or significant of those was the escalation pathway that was legislated by the parliament, which will allow essentially a review mechanism or an additional review mechanism, if you like, for outlier cases. We've also published the sorts of versions of the tool that the ombudsman asked us to do, and the department is going through the rest of the recommendations to ensure that we provide the fullest possible response to the ombudsman report.

JOURNALIST: Will there be a human override though? Will there be a change to the legislation for there to be a human override to the legislation?

BUTLER: That's what you see in the escalation pathway that we worked with the Parliament on, that will allow a delegate of the secretary to make a change where there is a case for someone to have extenuating circumstances. Yes?

JOURNALIST: Just on puberty blockers. Will anything change in terms of access while the guidelines are under review? And under the changes, are more clinicians given oversight over the prescription of these medicines?

BUTLER: Ultimately, the question, that's a question for state governments, really, because they operate these services. I made some remarks about what might or might not happen in the private sector, and we'll be monitoring that closely. But right now, as we understand that this is almost exclusively a service provided by state government gender clinics, so that will be a matter for them. I suspect that over the course of the next couple of months, while this is out for public consultation, I don't expect there to be much change in the operation of those clinics, but that's ultimately something you'd have to ask the state governments about. Yes?

JOURNALIST: Minister, just on Helen Haines. We got the news today that she's been discharged from hospital, and she's released a statement saying that it's positive news. Just wondering what your reflections are, and I guess have there been any conversations between, like, the Prime Minister and her recently as well?

BUTLER: Yeah, I can't comment on that, I'm sorry, but I think all of us welcome every milestone in Helen's recovery as wonderful news. We know these are devastating injuries though, and her road to recovery is going to be a long one. But each of these milestones that we've heard about over recent weeks have been so warmly welcomed by everyone in this building. I know, and people in the broader community as well. And we wish her and her family all the best.

JOURNALIST: Just on those ACT bulk billing questions, the $10.5 million that was provided to set up three standalone clinics here, the grant guidelines said that there had to be a certain number of GPs employed, and I understand that's essentially what the funding was for. But it seems like there's been a bit of a struggle to recruit enough GPs. Is that something that you're monitoring, or will the federal government be taking that money back if they don't actually fulfil the grant guidelines?

BUTLER: We're monitoring it closely. I don't have an answer for you now, but if there are some barriers, we want to see how we can overcome those barriers rather than take the money back, to use your terminology. I know recruitment of doctors is a bit of an issue in Canberra because of some of the recruitment rules that cover this city, but we'll work with those practices.

JOURNALIST: Heading into the mid-year Budget, are you concerned there will be cost blowouts in some areas versus savings in separate areas, given Treasury’s top actuary said he was not convinced that you could save $38 billion over four years?

BUTLER: I'm not going to speculate about the mid-year Budget review. We're working very hard on that, pretty much as we speak. On the Treasury actuary's commentary around this, I think if you read it closely, I think what the actuary says is pretty unremarkable, and that is that there's a lot of work to do to implement the changes that I announced at the press club and we delivered in the Budget. I'd be the first to admit that there's a lot of work to do to land those very significant reforms that we announced earlier this year, but they're on track. I'm very confident that we will deliver those savings. I'm determined to deliver those savings.

JOURNALIST: Do you think you'll deliver enough savings in this mid-year Budget to stay on track?

BUTLER: Oh well, I'm not going to speculate about the mid-year Budget. I'm happy to provide commentary about the changes we announced in the Budget six months ago to the NDIS which will deliver substantial savings. They're challenging, they're difficult to design. We're engaging with the community closely about that, but I'm confident we'll deliver the savings we announced in May.

JOURNALIST: Minister, you mentioned keeping an eye on the private prescribing of puberty blockers. What are the risks that becomes more prevalent if people are waiting almost two years to get the medication on average?

BUTLER: Obviously, wait times are significant for any patient. They're particularly significant for children and adolescents because development happens very quickly for them, and some of the mental health issues that are particularly associated with gender dysphoria can worsen quite quickly as well. I always urge state governments to do what they can to ensure that their services have the capacity to deal with growing demand. And this is an area where there has been growing demand.

To your question about private services, I don't have a particular view about public versus private here. If there are high quality private services that align with the sorts of guidelines that the NHMRC has announced, then there is the ability for those to operate here in Australia. But I would take some responsibility as the Federal Health Minister for ensuring that those private services, particularly private prescribers of medicines like puberty blockers, are aligning very, very closely with these with this advice. We have seen too many telehealth models develop over the last several years, where medicines have been prescribed without a close relationship between the prescriber and the patient, and I'm determined not to see that happen in this area.

JOURNALIST: Just on aged care, there's a story in the paper today that there's some rorting of the system. One example is people being charged huge amounts for nutritional smoothies. Do you believe that there is rorting of the system going on?

BUTLER: This is a new program and I've said, and I think Sam Rae has said, the new Support at Home program, the new pricing arrangements, they are going to take a little while to settle in a way that allows us to look at, you know, what- where the price cap should be put in place and the like. But the story this morning was pretty shocking, and I think every story, whether it's in residential care or Support at Home of older people being ripped off by providers, and being charged so far above the cost of delivering a good or a service is shocking to everyone in the community, including to me. The commission, Safety and Quality Commission, has powers to oversee these practises to order refunds, to take action against providers, and I absolutely expect the commission to do its job on that.

Yes. A couple of last ones, and then I have to go.

JOURNALIST: Minister, you said it's a new program but there have been dozens of reviews into the aged care system. Shouldn't some of these problems have been foreseen?

BUTLER: This was a new program in the sense that there are a lot of new services being delivered, a very different range of home care packages, if you like, being available to older people. Better packages, bigger packages, and so I don't think it's remarkable to expect that it will take a little while. It's still not, it's about 12 months for that pricing to settle down. We made it really clear, though, that prices have to be justifiable, have to be reasonable. We put in place caps on administrative charges in home care packages before we introduced this new system.

But I just want to make it really crystal clear to providers, as I have to residential aged care providers, they can't rip off older Australians. This is an important public service. In some cases, delivered by private providers, but they have the same accountability as if they were providing a public service.

Last one, then I'm going to go.

JOURNALIST: A year ago, a disability advocate and a wheelchair user tried to get into your electorate office in South Australia and couldn't get in because the only entrance had stairs. At the time, your office said they were looking at new locations to be more accessible. Do you have an update on that? Have you moved offices? Is there a more accessible way to get into your electorate office?

BUTLER: I think the person you're talking about was able to get in. There is a rear disability access, which is the reason why, when my electorate office was shifted some years ago, it was approved from a disability access point of view. Back as early as 2022 though, I think, I first asked the department, finance department, to find better disability access, either by changing the property that I'm currently in, or by finding me a new property. Now, it's a heritage property, so the ability to put in a front of house ramp apparently has been too difficult, but I've been extremely frustrated that we're at the end of 2026 and I'm still in this office. I've said it's not good enough. I said that some years ago to the department. I know people with disability who want to get into my office find it frustrating. I find it frustrating too. And right now, I understand the department signed a lease on a new property that has better disability access. And as far as I'm concerned, I can't get there quickly enough.

Thank you.